ArticleCancer chemotherapy and pharmacology2022

A phase I dose escalation, dose expansion and pharmacokinetic trial of gemcitabine and alisertib in advanced solid tumors and pancreatic cancer.

Justin A Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.